Novel peroral dosage forms with protease inhibitory activities. I. Design of capsules with fast gel-forming and fast drug-releasing properties

International Journal of Pharmaceutics

Volumn 136, Issue 1-2, 1996, Pages 155-163

  Akiyama, Yohko ^a   Lueßen, Henrik L ^b   De Boer, Albert G ^b   Verhoef, J Coos ^b   Junginger, Hans E ^b  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Carbomer (Carbopol 934P); Disintegrant; Freeze dried sodium Carbopol 934P; Microparticle; Peroral solid dosage form; Poly(acrylic acid) derivative; Poly(glycerol ester of fatty acid) (PGEF); Sodium Carbopol 934P

Indexed keywords

CARBOMER; ERYTHROSINE; POLYACRYLIC ACID; POVIDONE; STARCH GLYCOLATE SODIUM;

ARTICLE; DISSOLUTION; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; ENZYME INHIBITION; GEL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0343867237     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04505-8     Document Type: Article

References (23)

1. Akiyama, Y., Nagahara, N., Hirai, S. and Toguchi, H., In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids. Pharm. Res., 12 (1995) 397-405.
2. Bartunik, H.D., Summers, L.J. and Bartsch, H.H., Crystal structure of bovine β-trypsin at 1.5 Å resolution in a crystal form with low molecular packing density: active site geometry, ion pairs and solvent structure. J. Mol. Biol., 210 (1989) 813-828.
3. Bai, J.P.F., Distribution of brush-border membrane peptidases along the rat intestine. Pharm. Res., 11 (1994) 897 900.
4. Gabel, D. and Kasche, V., Autolysis of β-trypsin. Acta Chim. Scand., 27 (1973) 1971-1981.
5. Gissinger, D. and Stamm, A., A comparative evaluation of the properties of some tablet disintegrants. Drug Dev. Ind. Pharm., 6 (1980) 511-536.
6. Gruber, P., Longer, M.A. and Robinson, J.R., Some biological issues in oral, controlled drug delivery. Adv. Drug. Del. Rev., 1 (1987) 1-18.
7. Ishii, Y. and Fujii, Y., Effects of sodium polyacrylate (PANa) on peptic ulcers in rats. Pharmacometrics, 23 (1982) 55-62.
8. Kanig, J. and Rundic, E., The mechanisms of disintegrant action. Pharm. Technol., 8 (1984) 50-63.
9. Kawashima, Y., Takeuchi, H., Hino, T., Niwa, T., Lin, T.-L., Sekugawa, F. and Kawahara, K., Low-substituted hydroxypropylcellulose as a sustained release matrix base or disintegrant depending on its particle size and loading in formulation. Pharm. Res., 10 (1993) 351-355.
10. Lee, V.H.L., Dodda-Kashi, S., Crass, C.M. and Rubas, W., Oral route of peptide and protein drug delivery. In: Lee, V.H.L. (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, Inc., New York, 1991a, pp. 691-718.
11. Lee, V.H.L., Traver, R.D. and Taub, M.E., Enzymatic barriers to peptide and protein drug delivery. In: Lee, V.H.L. (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, Inc. New York, 1991b, pp. 303-359.
12. Lehr, C.-M., Bouwstra, J.A., Kok, W., De Boer, A.G., Tukker, J.J., Verhoef, J.C., Breimer, D.D. and Junginger H.E., Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat. J. Pharm. Pharmacol., 44 (1992) 402-407.
13. Leung, S.S., Nagai, T. and Machida, Y., Mucoadhesive dosage forms for peptide and protein drug delivery. In: Lee, V.H.L. (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, Inc., New York, 1991, pp. 741-767.
14. Lueßen, H.L., Lehr. C-M., Rentel, C-O., Noach, A.B.J., De Boer, A.G., Verhoef, J.C. and Junginger, H.E., Bioadhesive polymers for the peroral delivery of peptide drugs. J. Control. Rel., 29 (1994) 329-338.
15. Lueßen, H.L., Verhoef, J.C., Borchard, G., Lehr, C.-M., De Boer, A.G. and Junginger, H.E., Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm. Res., 12 (1995) 1293-1298.
16. 1,7]-eel calcitonin in rats using polyacrylic acid aqueous gel base. J. Pharm. Sci., 73 (1984) 1366-1368.
17. Morimoto, K., Iwamoto, T. and Morisaka, K., Possible mechanism for the enhancement of rectal absorption of hydrophillic drugs and polypeptides by aqueous polyacrylic acid gel. J. Pharmacobio-Dyn., 10 (1987) 85-91.
18. Morimoto, K., Miyazaki, M. and Kakemi, M., Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats. Int. J. Pharm., 113 (1995) 1-8.
19. Morita, T., Yamamoto, A., Takakura, Y., Hashida, M and Sezaki, H., Improvement of the pulmonary absorption of (Asu 1,7)-eel calcitonin by various protease inhibitors in rats. Pharm. Res., 11 (1994) 909-913.
20. Rundic, E.M., Kanig, J.L. and Rhodes, C.T., Effect of molecular variation on the disintegrant action of sodium starch glycolate. J. Pharm. Sci., 74 (1985) 647-650.
21. Rundic, E.M. and Rhodes, C.T., Evaluation of the disintegrant action. Drug Dev. Ind. Pharm., 8 (1982) 87-109.
22. Rundic, E.M. and Schwarz, J.B., Oral solid dosage forms. In: Gennaro, A.R. (Ed.), Remington's Pharmaceutical Science, Mack Publishing Company, Easton, Pennsylvania, 1990, pp. 1633-1665.
23. Zhou, X.H., Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs. J. Control. Rel., 29 (1994) 239-252.